129 related articles for article (PubMed ID: 21057746)
1. Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
Quéreux G; Renaut JJ; Peuvrel L; Knol AC; Brocard A; Dréno B
Acta Derm Venereol; 2010 Nov; 90(6):616-20. PubMed ID: 21057746
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
Corazza M; Zampino MR; Montanari A; Altieri E; Virgili A
Dermatology; 2003; 206(4):330-3. PubMed ID: 12771475
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.
Koens L; Senff NJ; Vermeer MH; Ronday HK; Willemze R; Jansen PM
Acta Derm Venereol; 2009 Nov; 89(6):653-4. PubMed ID: 19997706
[No Abstract] [Full Text] [Related]
4. Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas.
Tsimberidou AM; Giles FJ; Duvic M; Kurzrock R
J Am Acad Dermatol; 2004 Aug; 51(2):200-4. PubMed ID: 15280837
[TBL] [Abstract][Full Text] [Related]
5. Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma.
Chong BF; Wong HK
Clin Exp Dermatol; 2009 Jul; 34(5):e11-3. PubMed ID: 19040508
[TBL] [Abstract][Full Text] [Related]
6. Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk.
Pomerantz RG; Campbell LS; Jukic DM; Geskin LJ
Arch Dermatol; 2010 May; 146(5):513-6. PubMed ID: 20479299
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate and etanercept-induced primary cutaneous CD4 positive small/medium-sized pleomorphic T-cell lymphoma.
Ma H; Qiu S; Lu R; Feng P; Lu C
An Bras Dermatol; 2016; 91(3):368-71. PubMed ID: 27438209
[TBL] [Abstract][Full Text] [Related]
8. The rapid onset of multiple squamous cell carcinomas during etanercept treatment for psoriasis.
Ly L; Czarnecki D
Br J Dermatol; 2007 Nov; 157(5):1076-8. PubMed ID: 17854370
[No Abstract] [Full Text] [Related]
9. Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitis.
Mougel F; Dalle S; Balme B; Houot R; Thomas L
Dermatology; 2006; 213(3):239-41. PubMed ID: 17033176
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
Pulini S; Rupoli S; Goteri G; Pimpinelli N; Alterini R; Bettacchi A; Mulattieri S; Picardi P; Tassetti A; Scortechini AR; Fioritoni G; Leoni P
Eur J Haematol; 2009 Mar; 82(3):184-93. PubMed ID: 19215609
[TBL] [Abstract][Full Text] [Related]
11. Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate.
Huwait H; Wang B; Shustik C; Michel RP
Am J Dermatopathol; 2010 Feb; 32(1):65-70. PubMed ID: 20098085
[TBL] [Abstract][Full Text] [Related]
12. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
[No Abstract] [Full Text] [Related]
14. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab.
Mahé E; Descamps V; Grossin M; Fraitag S; Crickx B
Br J Dermatol; 2003 Jul; 149(1):170-3. PubMed ID: 12890213
[TBL] [Abstract][Full Text] [Related]
15. Etanercept combined with methotrexate for high-need psoriasis.
Driessen RJ; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
Li Y; Li Z; Lin HL; Chen XH; Li B
Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
Kannangara AP; Levitan D; Fleischer AB
J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
[TBL] [Abstract][Full Text] [Related]
18. Rapid onset and fatal outcome of two squamous cell carcinomas of the genitalia in a patient treated with etanercept for cutaneous psoriasis.
Comte C; Guilhou JJ; Guillot B; Dereure O
Dermatology; 2008; 217(3):284-5. PubMed ID: 18688171
[No Abstract] [Full Text] [Related]
19. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
Gisondi P; Cotena C; Tessari G; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous T-cell lymphoma bullosa: 2 cases].
Héliot I; Beylot-Barry M; Vergier B; Doutre MS; Beylot C
Ann Dermatol Venereol; 2003; 130(6-7):639-42. PubMed ID: 13679703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
